|
SEP-363856 Clinical Trials
3 actively recruiting trials across 3 locations
▲ +1 trial since September 2026
Also known as: Ulotaront
Pipeline
Phase 3: 3
Top Sponsors
- Otsuka Pharmaceutical Development & Commercialization, Inc.3
Indications
- Generalized Anxiety Disorder3
- Anxiety3
Tucson, Arizona1 trial
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
Del Sol Research Management
Phase 3
Redlands, California1 trial
A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
Anderson Clinical Research
Phase 3
Jacksonville, Florida1 trial
A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety Disorder
Clinical Neuroscience Solutions, LLC
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.